ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2026
Towards better outcomes for epidermal growth factor receptor L858R+ lung cancer patients: mutant-selective allosteric inhibitors and the potential for double-drugging.
Michael J Eck et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.